Taipei, Taiwan
Following a rigorous review by Boehringer Ingelheim’s corporate venture arm, interdisciplinary research teams, and business development experts, six biotech and digital health teams out of 89 submissions were named award winners of 2024 Boehringer Ingelheim BioMedicine Innovation Program. The winners represent a dynamic mix of innovators from clinical, academic, and industry backgrounds—with many showcasing cutting-edge AI and healthcare technology collaborations.
We are honored that Skyvor Medical’s AI-powered digital health platform has been recognized as a key enabler of next-generation, patient-centric clinical trials—empowering participants to engage in studies with greater flexibility and convenience than ever before.
We’re proud to help shape a future where clinical research is more accessible, efficient, and human-centered.